Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Human Bioequivalence of Triprerelin Acetate for Injection

NCT06683066 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT06683066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Phase 1
Overall status
Recruiting
Start date
December 4, 2024
Completion date
September 4, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (crpc)